The Cancer Institute NSW is leading implementation of the LBVC Breast Cancer Hypofractionation Initiative.
This initiative focuses on increasing access to hypofractionated radiotherapy for women with early-stage breast cancer at radiation oncology treatment centres across NSW.
Hypofractionated radiotherapy is recommended as the standard of care for most women with early-stage breast cancer. However, the proportion of women receiving hypofractionation varies across NSW treatment centres and local health districts.
Increasing hypofractionation rates has the potential to improve value in the key LBVC domains:
The Institute is supporting local health districts and specialty health networks to increase rates of hypofractionation by: